70261-58-4

Upstream product

• 100-39-0 benzyl bromide 
• 2942-40-7 nitro-4 indazole 
• 603-83-8 3-nitro-o-tolylamine 
• 100-44-7 benzyl chloride 
• 1073-62-7 N-benzylhydrazine hydrochloride 
• 606-31-5 2,6-dinitrobenzaldehyde 

Downstream Products

• 1313409-07-2 1-benzyl-3-bromo-4-nitro-1H-indazole 
• 1313409-08-3 1-benzyl-3-cyclopropyl-4-nitro-1H-indazole 
• 1313409-10-7 1-benzyl-3-cyclopropyl-1H-indazol-4-amine 
• 1313407-31-6 N-(1-benzyl-3-cyclopropyl-1H-indazol-4-yl)-7-(2-methoxyethoxy)imidazo[1,2-a]pyridine-3-carboxamide 

Relevant academic research and scientific papers

SUBSTITUTED N-(1H-INDAZOL-4-YL)IMIDAZO[1, 2-A]PYRIDINE-3- CARBOXAMIDE COMPOUNDS AS CFMS INHIBITORS

Compounds of Formula (I): and pharmaceutically acceptable salts thereof in which R1, R2, R3, R4 and R5 have the meanings given in the specification, are inhibitors of cFMS and are useful in the treatment of bone-related diseases, cancer, autoimmune disorders, inflammatory diseases, cardiovascular diseases and pain.

Alkylation and reduction of N-alkyl-4-nitroindazoles with anhydrous SnCl2 in ethanol: Synthesis of novel 7-ethoxy-N-alkylindazole derivatives

New series of indazoles substituted at the N-1 and N-2 positions and their 7-ethoxy derivatives have been synthesis starting from alkylation of 4-nitroindazole and reduction of alkyl-nitro-derivatives with anhydrous SnCl2 in ethanol. The structures of the